Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS
2
FDA accepts cefiderocol sNDA for serious gram-negative infections in children
3
Later transfer linked to longer hospitalization in severe congenital heart defects
4
TRAPEDS-1 evaluates tralokinumab in children with atopic dermatitis
5